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Ocular Reactivation of MCMV after Immunosuppression
of Latently Infected BALB/c Mice
Ming Zhang, Hua Xin, Yanping Duan, and Sally S. Atherton
PURPOSE. The purpose of this study was to identify the site(s) of
MCMV latency and reactivation in the eye.
METHODS. Three months after supraciliary inoculation of 5 
102 PFU of MCMV, BALB/c mice underwent immunosuppres-
sion with methylprednisolone and antibodies specific for CD4
T cells, CD8 T cells, and NK cells or with methylprednisolone
alone. Control mice were infected but did not receive the
immunosuppressants. After 2 or 3 weeks of immunosuppres-
sion, the mice were killed. Replicating virus and viral antigen
were detected in the injected eyes, peripheral blood leuko-
cytes (PBLs), and extraocular tissues by plaque assay and by
staining for early antigen (EA) and -galactosidase (-gal), re-
spectively.
RESULTS. In latently infected, nonimmunosuppressed control
mice, replicating-virus–and viral-antigen–positive cells were
not detected in the injected eyes or extraocular tissues. After
immunosuppression with methylprednisolone and antibodies,
EA and -gal were detected, and replicating virus was recov-
ered from the injected eye and from several extraocular sites,
including liver, lungs, salivary glands, and kidneys. No virus
was recovered from PBLs. -Gal- or EA-positive cells were
observed in the RPE of most mice, and a few virus-infected
cells were also observed in the nuclear layers and ganglion
cells. Microscopic changes, including retinal folding and de-
tachment, photoreceptor atrophy, macrophage infiltration,
and a few EA-positive cytomegalic cells, were observed in the
injected eye of immunosuppressed mice.
CONCLUSIONS. After immunosuppression, MCMV reactivates in
the injected eye and extraocular tissues, and RPE cells are the
initial site of MCMV ocular reactivation in the eye. The timing
of virus recovery from all sites suggests that MCMV observed in
the injected eye is from in situ reactivation of virus and not
from spread of virus from extraocular sites via infected PBLs.
(Invest Ophthalmol Vis Sci. 2005;46:252–258) DOI:10.1167/
iovs.04-0537
Human cytomegalovirus (HCMV) is a ubiquitous herpesvi-rus that generally causes asymptomatic infection, but it
may also cause pneumonitis, hepatitis, gastroenteritis, myocar-
ditis, and retinitis.1 Persons who are immunologically imma-
ture (neonates) or undergo immunosuppression (patients with
AIDS or recipients of organ allografts) are at risk of contracting
CMV-related diseases. The host specificity of HCMV has pre-
vented development of HCMV-infected animals as models to
study the pathogenic processes whereby HCMV infects human
cells, replicates within them, enters latency, and reactivates.2
Murine cytomegalovirus (MCMV) is a mouse-specific CMV that
causes pneumonitis, hepatitis, and retinitis in immunosup-
pressed mice.1–4 Like HCMV, MCMV becomes latent after
acute infection of immunocompetent mice.2, 5–10 Because of
similarities between HCMV and MCMV, MCMV-infected mice
have been used to study the pathogenesis of cytomegalovirus
infection and reactivation.
The eye is among the organs susceptible to CMV infection.
Before the introduction of highly active antiretroviral therapy
(HAART), CMV retinitis was the most common ocular oppor-
tunistic infection in patients with acquired immunodeficiency
syndrome. In the pre-HAART era, although the percentage of
patients with CMV retinitis varied depending on the study, up
to 46% of patients with AIDS could be expected to have HCMV
retinitis at some point during the course of the disease.11–13
The eye is also a target of congenital or neonatal CMV infection
because of an immature blood–retinal barrier.14,15 In patients,
HCMV retinitis may result from either a primary infection or
from reactivation of latent infection.12,14 A mouse model of
acute MCMV retinitis that shares some features with HCMV
retinitis has been used to study the pathogenesis of CMV
retinitis in immunosuppressed mice.3,4 Studies of latent and
reactivated MCMV infection, in which viral DNA was detected
in some inoculated eyes and extraocular tissues several months
after clearance of infectious virus from the eye and from all
extraocular sites, indicate that the virus becomes latent in the
injected eye and in some extraocular sites (such as the salivary
gland, kidney, spleen, liver, and lung) after initial ocular infec-
tion with MCMV.16–20 It has also been shown that immuno-
suppression induces reactivation of MCMV in the injected eye
and in some extraocular sites, as detected by recovery of
replicating virus20 and the presence of mRNA for gH, a late
protein.6 However, the site(s) of latency and reactivation of
MCMV in the eye of the mouse have not been defined. It is also
not known whether virus detected in the eye of immunosup-
pressed mice results from virus reactivation in situ in the eye or
whether virus detected in the eye results from the spread of
replicating virus from nonocular sites.
MATERIALS AND METHODS
Virus and Cells
Two strains of MCMV (RM461 and K181) were used in these experi-
ments. These viruses were kindly provided by Edward S. Mocarski and
Cheryl Stoddart (Department of Microbiology and Immunology, Stan-
ford University School of Medicine, Stanford, CA). RM461 was derived
by insertion of a modified Escherichia coli LacZ gene (under the
control of the HCMV major immediate-early promoter/enhancer) into
the wild-type MCMV K181 genome at the HindIII L/J site, just down-
stream of immediate-early gene 2 (ie2). RM461 expresses the E. coli
lacZ gene product -galactosidase (-gal) as an immediate-early viral
gene product during the viral replication cycle.21 Stocks of K181 were
prepared from the salivary glands of MCMV-infected BALB/c mice.
Stocks of RM461 were prepared in mouse embryo fibroblast (MEF)
cells (BioWhittaker, Walkersville, MD) grown in tissue culture medium
containing 5% fetal calf serum (HyClone, Logan, UT). The titer of
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MCMV in virus stocks was determined by duplicate plaque assay on
MEF cells.
Mice
Adult female BALB/c mice (Taconic Inc., Germantown, NY) were used
in all experiments. All mice were housed in accordance with National
Institutes of Health guidelines. Mice were maintained on a 12-hour
light–dark cycle and were given unrestricted access to food and water.
Mice were anesthetized with a rodent cocktail (0.5–0.7 mL/kg of a
mixture of 42.9 mg/mL ketamine, 8.57 mg/mL xylazine, and 1.43
mg/mL acepromazine) before experimental manipulation. The treat-
ment of animals in this study conformed to the ARVO Statement for the
Use of Animals in Ophthalmic and Vision Research and was approved
by the Institutional Animal Care and Use Committee of the Medical
College of Georgia.
Experimental Design
Immunocompetent adult female BALB/c mice were injected with 5 
102 plaque-forming units (PFU) of RM461 via the supraciliary route.
After 3 months (when replicating virus can no longer be recovered
from any ocular or nonocular site6), latently infected mice were di-
vided into three groups. Mice in group 1 were injected with methyl-
prednisolone acetate (2 mg/mouse, intramuscularly, every 3 days) and
with normal rat IgG (0.5 mg/mouse, intravenously, 1 day and 7 days
after beginning treatment with methylprednisolone). Mice in group 2
were treated with methylprednisolone acetate (2 mg/mouse, intramus-
cularly, every 3 days) and with intravenously injected, T-cell–specific
antibodies (0.45 mg anti-CD4 [GK1.5] and 0.1 mg anti-CD8 [2.43];
American Type Culture Collection, Manassas, VA) and anti-asialo GM1
(10 g/mouse; Wako Chemicals, Richmond, VA) 1 day and 7 days after
beginning treatment with methylprednisolone. Mice in group 3 (con-
trol) were injected with PBS only. Animals were killed after 2 or 3
weeks of immunosuppression (i.e., a minimum of 14 weeks after
inoculation of MCMV). Blood was collected by cardiac puncture and
anticoagulated with heparin, and the mice were perfused with PBS.
Spleens were harvested and single-cell suspensions were prepared for
flow cytometry. Peripheral blood leukocytes (PBLs) were separated
from blood (Histopaque-1119; Sigma-Aldrich, St. Louis, MO), according
to the manufacturer’s instructions. Eyes and extraocular tissues were
removed, snap frozen, and sectioned on a cryostat. The slides were air
dried and prepared for -gal staining or for immunohistochemistry. For
detection of reactivated replicating virus by plaque assay, the eyes,
nonocular tissues, and PBLs were homogenized in serum-free tissue
culture medium, with a hand-held tissue homogenizer (Biospec Prod-
ucts, Inc., Racine, WI). The homogenates were serially diluted and
plated (in duplicate) on MEF cells.
For in vitro reactivation of latent MCMV, the eyes of latently
MCMV-infected, nonimmunosuppressed mice were removed and sep-
arated into anterior and posterior segments with a dissecting micro-
scope. The fragments of each segment of a single eye were placed in
separate culture plate inserts (Millicell; Millipore, Bedford, MA) with a
pore size of 3.0 m, and each culture plate insert was placed in a well
containing a monolayer of MEF cells. By this method, reactivated virus
released from the tissue diffuses into the medium and infects the MEF
cells. Because there is no direct contact of the minced tissue with the
MEF cells, the cellular toxicity that frequently results from such contact
is eliminated. After 1 day and then every 7 days thereafter, the culture
plate inserts containing the minced tissue were removed to another
well containing a fresh monolayer of MEF cells until the ocular frag-
ments had been in culture for 3 weeks. MEF cultures were fixed and
stained for virus plaques 3 weeks after the culture plate inserts had
been removed.
Flow Cytometry
The non–cross-reactive antibodies FITC-anti-L3T4 (BD-PharMingen,
San Diego, CA), PE-anti-ly-3.2 (BD-PharMingen), and FITC-anti-mouse
pan-NK (BD-PharMingen), recognizing CD4, CD8, and DX5 (NK), re-
spectively, were used to determine the extent of lymphocyte deple-
tion. Flow cytometry of stained spleen cell samples was performed
(FACStar Flow Cytometer; BD Biosciences, San Jose, CA), and the flow
cytometry results were analyzed using DP2 software (provided by the
National Institutes of Health, Bethesda, MD).
Immunohistochemistry
Monoclonal antibody to an MCMV early gene product22 was biotinyl-
ated (Sulfo-NHS-LC-Biotin; Pierce, Rockford, IL) according to the man-
ufacturer’s instructions. Frozen sections of ocular tissues were fixed
with acetone for 5 minutes at room temperature. The slides were
rinsed twice with PBS, and the sections were blocked with 3% normal
goat serum (Vector Laboratories, Burlingame, CA) for 30 minutes.
Biotin-labeled anti-EA was applied to the sections for 90 minutes at
room temperature in a humidified chamber. The slides were then
washed twice with PBS, treated with 0.5% H2O2 in absolute methanol
for 30 minutes, and washed twice with PBS. Sufficient avidin-biotin
complex (ABC) solution (ABC kit; Vector Laboratories) to cover the
sections was applied for 45 minutes at room temperature in a humid-
ified chamber. The slides were washed three times with PBS and
incubated with 3,3-diaminobenzidine (DAB; Sigma-Aldrich) at room
temperature for 10 to 30 minutes. The reaction was stopped by
washing slides in tap water. The sections were counterstained with
methyl green, dehydrated, mounted, and examined microscopically for
brown-stained cells, indicative of EA expression.
Monoclonal antibody against RPE65 (kindly provided by Michael
Redmond, National Eye Institute, National Institutes of Health) was
used to stain the cells of the retinal pigment epithelium (RPE).23 After
they were blocked, the sections were incubated overnight at 4°C in
primary antibody to RPE65 (1:400) and then washed and incubated
with Texas-red–labeled anti-rabbit (1:100; Vector Laboratories). Anti-
body to MCMV EA was labeled with FITC (Sigma-Aldrich) according to
the manufacturer’s instructions. To double stain MCMV EA and RPE65,
the sections were stained first with anti-RPE65 and then reacted with
FITC-labeled anti-MCMV EA. The slides were mounted with antifade
mounting medium containing 4,6-diamino-2-phenylindole (DAPI;
Vectashield; Vector Laboratories) and examined with a confocal mi-
croscope for MCMV EA-positive green cells (FITC) and RPE65-positive
red cells (Texas red). Biotin anti-mouse CD11b (Mac-1, 1:50; BD
PharMingen) was used to stain macrophages/macroglia. Immunohisto-
chemistry was conducted with Texas red–labeled avidin (Vector Lab-
oratories). FITC-labeled anti-mouse CD3 (1:50; BD PharMingen) was
used to stain T cells.
Staining for -Gal in Frozen Sections
Frozen sections of ocular and nonocular tissues were fixed with 0.5%
glutaraldehyde in PBS for 15 minutes and washed twice with PBS. The
sections were reacted with X-gal (5-bromo-4-chloro-3-indolyl--D-galac-
topyranoside) a chromogenic substrate for -gal. After incubation over-
night at room temperature in substrate solution (PBS containing 2.4
mM X-gal, 12.5 mM K3FeCN6, and 12.5 mM K4FeCN63H2O), the
sections were washed with PBS and counterstained with safranin-O.
Tissue sections were dehydrated, mounted, and examined microscop-
ically for blue-stained cells, indicative of immediate early (IE) gene
expression.
RESULTS
In Vitro Reactivation of Ocular MCMV
To determine whether MCMV is latent in the eye, injected eyes
were collected from nonimmunosuppressed mice that were
latently infected with MCMV. After separation, the anterior and
posterior segment of each eye was cocultivated separately with
MEF cells using a culture plate insert (Millicell; Millipore), as
described in the Materials and Methods section. The results
showed that replicating virus was not detected in either the
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anterior or posterior segment of any injected eye immediately
after the mice were killed (1 day). After 1 week of culture, virus
was detected in the anterior segment of 1 of 10 mice and in the
posterior segment of 1 of 10 mice. After 2 weeks of culture,
virus was detected in 1 of 10 anterior segments and 3 of 10
posterior segments. After 3 weeks in culture, replicating virus
was recovered from 9 of 10 anterior and posterior segment
samples.
Lymphocyte Depletion
The extent of splenic lymphocyte depletion was assessed after
2 or 3 weeks of immunosuppression of mice latently infected
with MCMV and treated with methylprednisolone alone (group
1) or with methylprednisolone together with T-cell–and NK-
cell–specific antibodies (group 2). As shown in Table 1, after
treatment with methylprednisolone alone (group 1), 99% of
spleen cells were depleted. Continued treatment did not sig-
nificantly affect the extent of overall cell depletion, but the
relative percentage of CD4 and CD8 cells decreased. Among
the mice in group 2, treatment with T-cell–and NK-cell–spe-
cific antibodies in addition to methylprednisolone resulted in
only slightly more depletion of total spleen cells. However,
more CD4 and CD8 cells were depleted in the mice in
group 2 than in the mice in group 1. For example, after 3
weeks of immunosuppression, the actual number of CD4 and
CD8 cells in the mice in group 2 was reduced 33- and
136-fold, respectively, compared with the number of CD4
and CD8 cells in the mice in group 1.
Reactivation of MCMV in
Immunosuppressed Mice
To determine whether MCMV reactivates in immunosuppressed
mice, eyes, extraocular tissues, and PBLs were collected from
immunosuppressed mice after 3 weeks of immunosuppression
and from latently infected, nonimmunosuppressed control
mice. Replicating, reactivated virus was recovered from the
injected eye, the lungs, and the liver of the mice in group 2
(Table 2). Replicating virus was not recovered from these
tissues in mice in group 1 or in mice in the nonimmunosup-
pressed control group. In addition, replicating virus was not
recovered from the noninjected eye, salivary glands, kidneys,
spleen, or PBLs of any mouse in any group.
Ocular Viral Antigen in Immunosuppressed Mice
Even though the virus-recovery studies show that MCMV reac-
tivated in the injected eye of immunosuppressed mice, virus
recovery provided no information about the sites in which
virus had reactivated in the eye. To determine the location of
reactivated MCMV, injected eyes from mice in each group
were examined for -gal (expressed as an IE gene) and/or for
EA after 2 or 3 weeks of immunosuppression. As shown in
Table 3, viral antigen was detected in the RPE of one of four
mice in group 1 after 3 weeks of immunosuppression. In
contrast, among mice in group 2, more animals and more sites
were positive for viral antigen after 2 weeks of immunosup-
pression. Among eyes in which viral antigen was detected, the
RPE layer appeared to be the initial and most frequent site of
MCMV reactivation (Fig. 1B), although positive cells were ob-
served occasionally in other sites, including the nuclear layers
and the ganglion cells (Fig. 1C), the choroid (Fig. 1B), and the
anterior segment (Fig. 1D). The pattern of EA staining was
similar to that of -gal staining, and -gal-positive cells were
usually observed in the same sites as EA-positive cells in adja-
cent sections (for example, Figs. 1E, 1F). As was observed with
-gal staining, the RPE layer of only one mouse in group 1 was
EA positive, whereas most of the animals in group 2 expressed
viral antigen in the RPE as well as in several other sites in the
posterior and anterior segments (Table 4). None of the injected
eyes of the mice in group 3 was positive for viral antigen (Fig.
1A).
To ensure that the results from experiments using immu-
nosuppressed mice latently infected with RM461 were not
influenced by insertion of the LacZ gene into the MCMV
genome, mice latently infected with the parent virus K181
underwent immunosuppression with methylprednisolone and
antibodies specific for CD4, CD8, and asialo-GM1, and sites of
EA expression were identified. After 3 weeks of immunosup-
pression, EA-positive cells were observed in the RPE layer of
the injected eye of four of five of the mice and occasionally in
other sites in both the posterior and the anterior segment. No








Gland Lung Liver Kidney Spleen PBL
1 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5
2 3/5 0/5 0/5 4/5 1/5 0/5 0/5 0/5
3 0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/3
Groups are described in Table 1. The first number is the number affected, and the second number is
the number in the group.


















1 2 5.4  105/99.19 2.1  105 39.55/98.28 8.3  104 15.35/98.26 1.1  104 1.94/99.53
3 3.0  105/99.55 3.1  104 10.40/99.75 1.5  104 4.85/99.69 NT NT
2 2 3.3  105/99.51 1.2  104 3.50/99.91 5.6  102 0.17/100.00 6.7  103 1.94/99.74
3 2.8  105/99.58 9.2  102 0.33/100.00 1.1  102 0.0/100.00 NT NT
3 — 6.7  107/— 1.2  107 18.50/— 4.8  106 7.10/— 2.7  106 4.05/—
Group 1, latently infected mice treated with methylprednisolone only; group 2, latently infected mice treated with methylprednisolone and
T-cell— and NK-cell–specific antibodies; group 3, nonimmunosuppressed mice latently infected with MCMV. NT, not tested.
* %Depletion compared with the controls (group 3).
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EA-positive cells were observed in the injected eye of control
mice. After immunosuppression, replicating virus was recov-
ered from the injected eye of four of five mice, the salivary
glands of four of five mice, and the lungs of three of five mice
infected with the parent virus. No replicating virus was recov-
ered from other sites, including the uninjected eye, kidneys,
spleen, or PBLs.
To determine whether viral-antigen–positive, MCMV-in-
fected cells in the area of the RPE were RPE cells, sections of
eyes from latently infected, immunosuppressed mice were
double stained with antibodies specific for MCMV EA and for
RPE-65. As shown in Figure 2, most of the EA-positive cells in
the area of the RPE were also RPE-65 positive.
Microscopic Changes Associated with
Reactivation of MCMV in the Eye
Although typical MCMV retinitis and retinal destruction were
not observed in immunosuppressed mice in either group 1 or
2, reactivation of virus was associated with several microscopic
changes in the eye. The most common finding (9/15 mice) was
retinal detachment and loss of the photoreceptors that ap-
peared to be associated with the presence of virus in the RPE
(Figs. 3A, 3B). EA-positive cytomegalic cells were also observed
occasionally in injected eyes of immunosuppressed mice (Fig.
3C). Some viral-antigen–negative, macrophage-like cells were
also present in the retina of these mice (Fig. 3D).
Immune Cells in the Retina of Mice Latently
Infected with MCMV
To determine the identity of the macrophage-like cells, we
stained sections of the eyes of normal mice and of mice latently
infected with MCMV before and after immunosuppression
with antibodies for Mac-1 and CD3. In normal mice, Mac-1–
positive cells were occasionally found in the RPE layer (Fig.
4A), but no T cells were observed (Fig. 4B). Before immuno-
suppression of latently infected mice, some Mac-1- (Fig. 4C)
and CD3- (Fig. 4D) positive T cells were observed in the
injected eye, primarily in the choroid, the RPE, and photore-
ceptor layer. After 3 weeks of immunosuppression with meth-
ylprednisolone and antibodies, Mac-1-positive cells were ob-
served in all layers of the retina (Fig. 4E), whereas only an
occasional CD3-positive T cell was seen (Fig. 4F).
DISCUSSION
Similar to other members of the herpesvirus family, the CMVs
remain with their host and establish lifelong latency after
primary infection. Depending on the host and viral system, the
question of whether the virus is truly latent or maintains a
low-level, persistent viral infection has not been completely
resolved. Operationally, latency has been defined as the inabil-
ity to detect replicating virus despite the presence of virus
DNA and perhaps some limited transcription. In the murine
models of MCMV infection, latency is characterized by the
ability to reactivate virus from cells of infected tissues after
cocultivation with permissive cells in culture, even though
infectious virus cannot be detected directly in disrupted tis-
sues.24,25 Immunosuppression6,8,9,20 or immunologic modula-
tion, such as allogeneic stimulation,26,27 has been shown to
induce reactivation of latent virus.
The eye is among several organ targets of CMV infection.
The results of the studies reported in this manuscript support
the idea that after inoculation of MCMV via the supraciliary
route, virus becomes latent in the eye and that latent virus may
reactivate in the eye. Results from several studies suggest that
FIGURE 1. Photomicrographs of MCMV in the injected eye of latently
infected BALB/c mice. No MCMV (-gal)-positive cells were observed
in the eyes of nonimmunosuppressed, latently infected mice (A).
-Gal-positive cells were observed in the eye after 3 weeks of immu-
nosuppression with methylprednisolone and antibodies (B–E, ar-
rows). The RPE was the initial and most frequent site of MCMV
reactivation (B). -Gal-positive cells were observed occasionally in
other sites, including the nuclear layers and the ganglion cell layer (C),
the anterior segment (D), and the choroid (B). The pattern of EA
staining (F, arrows) was similar to that observed for -gal staining (E,
arrows), and -gal-positive cells were usually observed in the same
sites as EA-positive cells in adjacent sections (compare Figs. E and F).











1 2 0/4 0/4 0/4 0/4 0/4 0/4
3 0/4 0/4 1/4 0/4 0/4 0/4
2 2 1/8 1/8 6/8 1/8 1/8 3/8
3 2/8 2/8 7/8 3/8 3/8 3/8
3 — 0/5 0/5 0/5 0/5 0/5 0/5
Groups are described in Table 1. Data are as described in Table 2.
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MCMV becomes latent in the eye after ocular (anterior cham-
ber or intravitreal) or intraperitoneal inoculation. Bale et al.18
reported that the eyes of 10% of mice infected with MCMV via
the intraperitoneal route were positive for virus during latency.
In later studies, use of in situ hybridization during acute infec-
tion after anterior chamber inoculation demonstrated that cells
of the uveal tract are permissive of MCMV.17 In the same
studies, when latently infected mice underwent immunosup-
pression with cortisone acetate and antilymphocyte serum,
infectious virus was recovered from 60% of the salivary glands
and from 20% of the eyes, whereas none of the leukocytes was
virus positive, confirming that MCMV becomes latent in the
eye and was not spread to the eye via leukocytes harboring
replicating virus. In another study, after inoculation of young
(12- to 18-day-old) mice via the anterior chamber, latent MCMV
was recovered from a small number of eyes by cocultivation
several months after the acute infection and after clearance of
infectious virus from all sites.19
In a study by Rabinovitch et al.,20 intravitreal injection of
3-week-old BALB/c mice with MCMV resulted in mild chori-
oretinitis during the acute phase of the virus infection and that
virus was cleared from all ocular structures within 2 weeks of
virus inoculation. When the mice in this study were subjected
to immunosuppression with cortisone acetate and cyclosporin
A, replicating virus was recovered from the eye.20 Previous
results from our laboratory showed that after inoculation of
5  102 PFU of MCMV (RM461 or Smith strain) into the
supraciliary space of euthymic BALB/c mice, replicating virus
was cleared from salivary gland by 5 weeks after infection (PI)
and other sitesm including injected eyes, by 4 weeks PI. -gal-
positive, virus-infected cells were cleared from all sites by day
28 PI.16,28 More recent studies by Kercher and Mitchell29 using
PCR and virus recovery demonstrated that MCMV becomes
latent in the eye after inoculation via the supraciliary route.
However, after immunosuppression of these mice with cyclo-
phosphamide, replicating virus was recovered only after ex-
plantation of the ocular tissue and not directly from the eyes of
the immunosuppressed mice. Taken together, the results of
many studies of MCMV showing that replicating virus cannot
be detected in the eyes of latently infected, nonimmunosup-
pressed mice after inoculation of virus via several ocular routes
support the idea that a low level of replicating virus does not
persist in the eye after acute ocular infection. Because repli-
cating virus was recovered from both the anterior and poste-
rior segments of the eye after cocultivation in vitro, these
findings suggest that virus is latent in structures in both the
anterior the posterior segments.
Early antigen (EA) and immediate EA were detected, and
replicating virus was recovered from the injected eyes and
some extraocular tissues of immunosuppressed mice, indicat-
ing that MCMV can reactivate in the injected eyes and extraoc-
ular tissues after immunosuppression. However, ocular reacti-
vation of latent MCMV was observed only in mice that had
undergone deep immunosuppression with a combination of
methylprednisolone and antibodies. These results are at vari-
FIGURE 3. Photomicrographs of tissue changes associated with
MCMV reactivation in the injected eyes after immunosuppression of
mice latently infected with MCMV. MCMV-positive cells were observed
in the RPE, and retinal detachment was observed (A, B, arrows).
MCMV-positive cytomegalic cells (arrows) were seen in the retina (C)
and RPE (B). Infiltration of -gal (virus) negative macrophage-like cells
was noted in the retina (D, arrows).




Anterior Segment Posterior Segment





1 2 0/4 0/4 0/4 0/4 0/4 0/4
3 0/4 0/4 1/4 0/4 0/4 0/4
2 2 0/5 0/5 3/5 0/5 1/5 1/5
3 1/5 1/5 3/5 2/5 2/5 0/5
3 — 0/3 0/3 0/3 0/3 0/3 0/3
Groups are described in Table 1. Data are as described in Table 2.
FIGURE 2. Photomicrographs of double staining for MCMV EA and
RPE-65 in the injected eyes after immunosuppression of mice latently
infected with MCMV. MCMV EA-positive cells in the RPE layer (A),
RPE-65-positive cells (B), DAPI nuclear-stained cells (C), and a merged
image indicating that the EA-positive cells in the RPE were also RPE-65
positive (D).
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ance with those reported in latently infected mice that had
cyclophosphamide immunosuppression alone29 and suggest
that both the type of and the extent of cell deletion are
involved in determining whether replicating virus is recovered
from ocular tissues. When mice were treated for 3 weeks with
methylprednisolone alone, only a few EA- or IEA-positive RPE
cells were observed in the eye of a single mouse, and replicat-
ing virus was not recovered from any ocular or extraocular site.
In contrast, in deeply immunosuppressed mice (treated with
methylprednisolone and antibodies), the injected eyes of most
of the mice were EA- or -gal-positive as early as 2 weeks after
the initiation of immunosuppression, and replicating virus was
recovered from injected eyes and extraocular sites, including
liver, lung, and salivary gland after 3 weeks of treatment.
Although after 3 weeks of treatment the total number of spleen
cells was similar in the mice treated with methylprednisolone
plus antibodies and the mice treated with methylprednisolone
alone, flow cytometric analysis revealed that more CD4 and
CD8 cells were depleted in the mice treated with methyl-
prednisolone and antibodies than in the mice treated with
methylprednisolone alone. Because depletion of CD4 and
CD8 T cells was nearly 100% after 3 weeks of deep immuno-
suppression, this finding suggests that extensive depletion of T
cells is needed before MCMV can reactivate and replicate in the
eye of latently infected mice.
After inoculation of 5  102 PFU of RM461, virus spread to
the anterior and the posterior segments of the injected eye, as
well as to some extraocular sites.14,25 Although a few -gal-
positive cells were also observed in the nuclear layers, the RPE
cells appeared to be the initial and major targets of acute
MCMV infection after inoculation of virus via the supraciliary
route.16,28 These studies showed that when latently infected
mice had 3 months of immunosuppression after virus inocula-
tion, MCMV reactivated in the eye, and the sites of MCMV
reactivation in the injected eye were similar to the sites during
acute infection. RPE was also the initial and major site of
MCMV reactivation. Many -gal- or EA-positive cells were found
in the RPE of most mice 2 or 3 weeks after immunosuppres-
sion, although occasional virus-positive cells were observed in
the anterior segment, nuclear layers, ganglion cells, and cho-
roid. Our present results, as well as previous studies in our
laboratory6 and in that of other investigators,18 indicate that
MCMV cannot be recovered from PBLs after immunosuppres-
sion. Our previous studies of latency also showed that although
PBLs contain viral genomes, late antigen (gH) RNA could not
be detected in immunosuppressed mice.6,16 These results, to-
gether with other observations that noninjected eyes were
negative for virus; that the choroid and ciliary body, but not the
RPE, became infected during systemic infection of immuno-
suppressed mice28,30; and that latent virus was reactivated in
vitro from injected eyes by cocultivation suggest that some or
perhaps all of the virus recovered from the eye results from in
situ reactivation of latent virus and subsequent replication and
not from spread of replicating virus from nonocular sites via
MCMV-infected PBLs.
Our results also showed that the sites of EA expression in
the injected eyes of IS mice latently infected with parent
MCMV K181 were similar to the mice infected with the mutant
virus RM461. Replicating virus was also recovered from in-
jected eye and lung in both groups. The results confirmed
previous observations from our laboratory31 and from others21
that these two strains of MCMV replicate similarly in the eye, as
well as in several other organs, such as the lung and liver.
RM461 replication in these tissues was not influenced by in-
sertion of the LacZ gene into the MCMV genome. In the studies
described herein, replicating virus was recovered from the
salivary glands of four of five mice infected with K181, but no
virus was recovered from salivary glands of mice latently in-
fected with RM461. Replication of RM461 in the salivary gland
is lower than that of the parent virus, K181, because RM461
contains the lacZ gene inserted close to the sgg1 gene, which
regulates MCMV replication in salivary glands.21
After immunosuppression, microscopic changes such as
retinal detachment and loss of photoreceptors and occasional
cytomegalic cells were observed in the retina of the injected
eye of MCMV latently infected mice. These changes appeared
to be due to reactivation of MCMV in the eye and not to an
effect of the immunosuppression, since comparable changes
were not observed in the noninjected eyes of immunosup-
pressed mice. In addition, because the microscopic appear-
ance of the retinas of the injected eyes of nonimmunosup-
pressed mice latently infected with MCMV remained normal, it
is unlikely that the retinal changes were due to the virus
injection or to the limited amount of viral replication that
occurs after supraciliary inoculation of MCMV.
Resting microglia moderately express CD11b, which is rap-
idly upregulated after activation.32 Our results showed that
more Mac-1-positive cells were observed in the retina of the
injected eye after immunosuppression. The role these acti-
vated microglia play in retinal damage during replication of
replicated virus is not clear. Although viral antigen-positive
cells were observed in the retina of the injected eye after
immunosuppression, fulminant retinitis was not observed ,and
the titer of replicating virus in the eye was low (average 40
PFU/eye). Immune cells in situ such as activated microglia may
play a role in the restriction of viral replication and spread in
the retina. Alternatively, because activated retinal microglia are
associated with degenerative retinal diseases and photorecep-
tor loss,33–37 the microscopic changes observed in the retina of
FIGURE 4. Photomicrographs of immune cells (arrows) in the eyes. A
few Mac-1-positive cells (A) but no T cells were observed in the RPE of
normal mice (B). Mac-1-positive cells (C) and CD3-positive T cells (D)
were observed in the choroid, RPE, or photoreceptor layer in the
injected eyes of nonimmunosuppressed latently infected mice. After 3
weeks of immunosuppression, few CD3-positive T cells were observed
in the injected eye (E). Mac-1-positive cells were present in all layers of
the retina (F).
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immunosuppressed, latently infected mice may be attributable
to the effects of these cells.
The result that virus reactivated in situ in the mouse eye
during immunosuppression suggests that spread of virus from
nonocular sites or from systemic infection may not always be
necessary for induction of CMV retinitis. Although most CMV
infections of the retina are coincident with systemic CMV
infection, some patients who are congenitally infected with
HCMV and in whom HCMV retinitis develops do not have
evidence of concurrent systemic CMV infection.14
Although it has been suggested that reactivation of MCMV is
differentially regulated in the eye,29 the results of the studies
presented herein suggest that the extent and timing of immu-
nosuppression are also critical elements during in vivo viral
reactivation. Although the preponderance of the evidence sug-
gests that virus can reactivate in the eye of the mouse, addi-
tional studies are needed to determine why reactivation of
ocular virus does not lead to fulminant retinitis, even in deeply
immunosuppressed mice.
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